International, Randomized, and Controlled Clinical Study, to Evaluate the Clinical Benefit of the ERA Test in Infertile Patients Undergoing Assisted Reproduction Treatment and Medical Indication of PGT-A
Year: 2025
Type: dissertation
Abstract: Contemporary lifestyle modifications have postponed conception, rendering ad- vanced maternal age a significant risk factor for female infertility. It is well established that advancing maternal age is strongly correlated with deteriorating oocyte quality and an increased risk of chromosomal abnormalities in oocytes and embryos. However, the reduction in fertility with age is not solely due to ovarian factors. Advances in assisted reproductive technology (ART), such as oocyte donation and the selection of viable embryos through preimplantation genetic testing for chromosomal abnormali- ties (PGT-A), have addressed several ovarian-related challenges associated with advanced maternal age. Nevertheless, other variables, particularly endometrial aging, significantly influence implantation rates, clinical pregnancy rates, live birth rates, and overall female fertility in women of advanced age. Molecular biological techniques have significantly transformed assisted reproduction. Numerous couples facing infertility issues have successfully achieved the birth of healthy infants, even at an advanced age, through the utilization of two molecular biology methods: PGT-A and endometrial receptivity analysis (ERA). It is noteworthy that oocytes play a crucial role in the reproductive aging of women. However, given the pivotal role of the endometrium in facilitating embryo implantation and subsequent pregnancy, exploring the impact of age on endometrial assays via tests like the ERA provides valuable insights. This underscores an important aspect of age-related fertility decline that extends beyond ovarian considerations. While advancements in ART, including oocyte donation and PGT-A, have successfully tackled some of the difficulties linked to ovarian aging, there is a growing acknowledgment that other factors, particularly the aging of the endometrium, substantially influence reproductive outcomes for women of advanced age. With advancing age, alterations in the endometrium may occur, potentially impacting implantation rates, clinical pregnancy rates, and live birth rates. The clinical relevance of endometrial receptivity analysis (ERA) lies in its ability to guide personalized embryo transfer (pET) by aligning the embryo transfer (ET) with the pa- patient's distinctive window of implantation (WOI). This synchronization proves to be particularly beneficial for patients experiencing implantation failure due to endometrial factors. By leveraging ERA, clinicians can tailor the timing of ET to coincide with the individual's endometrial receptivity profile, thereby optimizing the probability of successful implantation through a personalized approach and ultimately enhancing overall reproductive outcomes. Achieving comparable outcomes to those seen in patients of younger reproductive age is feasible in patients of advanced age. Examining these effects within in-vitro fertilization (IVF) studies involving oocyte donation cycles offers valuable insights for clinicians and researchers in customizing fertility treatments. It underscores the necessity for a comprehensive approach to assisted reproduction, considering both ovarian and endometrial factors to optimize outcomes for women undergoing fertility treatments later in life. Nonetheless, the lack of published studies on this topic indicates that further exploration is needed to enhance our understanding of methods for improving ART outcomes in advanced maternal age. This study aims to improve ART outcomes with pET according to ERA in advanced-age patients with challenging reproductive histories and recurrent implantation failure (RIF) by utilizing donor oocytes and PGT-A for embryo testing.
Author: Barbakadze, Tamar
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: endometrial receptivity analysis, advanced maternal age, preimplantation genetic testing for aneuploidy, oocyte donation, personalized embryo transfer, implantation window, female infertility, implantation failure, reproductive aging, embryo transfer timing, clinical pregnancy rate, live birth rate, implantation rate, oocyte quality, embryo quality, embryo cryopreservation
Open Access status: green
OpenAlex ID: W7048264609
